Athena Neurosciences, Inc. Issues Statement To Correct Dow Report.SOUTH SAN FRANCISCO South San Francisco, city (1990 pop. 54,312), San Mateo co., W Calif.; inc. 1908. South San Francisco has several industrial parks; its manufactures include medical supplies and equipment, foods, paint, paper products, consumer goods, and clothing. , Calif.--(BUSINESS WIRE)--Aug. 16, 1995-- Athena Neurosciences, Inc. (Athena)(Nasdaq: ATHN) issued a statement today regarding the use of the word "conclusive" in a recent report issued on the Dow Jones Dow Jones the best known of several U.S. indexes of movements in price on Wall Street. [Am. Hist.: Payton, 202] See : Finance News Service on the status of its Alzheimer's diagnostic test services. John Groom, Athena's president and chief executive officer, said "A report published earlier today on the Dow Jones News Service describes Athena as having developed conclusive tests for the diagnosis of Alzheimer's disease Alzheimer's disease (ăls`hī'mərz, ôls–), degenerative disease of nerve cells in the cerebral cortex that leads to atrophy of the brain and senile dementia. . The use of the word `conclusive' is inaccurate and inappropriate. We believe the test panel we are developing will be useful in ruling in or out Alzheimer's disease with ninety percent or more accuracy in a majority of patients tested. As described in our detailed press release issued yesterday, the ApoE test is a blood test to identify symptomatic individuals' apolipoprotein E apolipoprotein E A 34-kD cholesterol-binding glycoprotein, which comprises 15% of VLDL; apoE maps to chromosome 19, is secreted by macrophages that mediate the uptake of lipoproteins–VLDL, HDL, LDL and cholesterol esters into cells via distinct binding allele allele (əlēl`): see genetics. allele Any one of two or more alternative forms of a gene that may occur alternatively at a given site on a chromosome. genotype. The presence of an E4 allele significantly increases the probability that a person's dementia is due to Alzheimer's disease, but it is not a conclusive test. We plan to add additional tests that identify in cerebral spinal fluid spinal fluid n. See cerebrospinal fluid. the levels of tau and a form of a beta-peptide. These proteins respectively constitute the major elements of the tangles and plaque that characterize Alzhemier's pathology in the brain. Our data to date indicate that, in demented individuals, high levels of tau are linked to the presence of Alzheimer's disease, while high levels of beta-peptide are correlated with the absence of Alzheimer's disease. However, before either of these tests are made available, we would expect to obtain consensus and support from appropriate experts as to their value and use," Groom concluded. Athena Neurosciences, Inc. was founded in 1986 and is engaged in the discovery, development and marketing of products and services to be used primarily by neurologists for the treatment and diagnosis of neurological disorders This is a list of major and frequently observed neurological disorders (e.g. Alzheimer's disease), symptoms (e.g.back pain), signs (e.g. aphasia) and syndromes (e.g. Aicardi syndrome). . CONTACT: Athena Neurosciences, Inc. John Groom, 415/877-0900 (President & Chief Executive Officer) |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion